BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang G, Tanaka A, Zhao H, Jia J, Ma X, Harada K, Wang FS, Wei L, Wang Q, Sun Y, Hong Y, Rao H, Efe C, Lau G, Payawal D, Gani R, Lindor K, Jafri W, Omata M, Sarin SK. The Asian Pacific Association for the Study of the Liver clinical practice guidance: the diagnosis and management of patients with autoimmune hepatitis. Hepatol Int 2021;15:223-57. [PMID: 33942203 DOI: 10.1007/s12072-021-10170-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang X, Huang A, Lu Y, Gao S, Hu W, Cheng H. Drug-induced liver injury associated with dacomitinib: A case report. Front Oncol 2022;12:979462. [DOI: 10.3389/fonc.2022.979462] [Reference Citation Analysis]
2 He T, Ren L, Gong M, Guo Y, Wang L, Xiao X, Wang R, Bai Z. The progression of chronicity and autoimmune hepatitis in recurrent drug-induced liver injury. Clin Res Hepatol Gastroenterol 2022;46:102009. [PMID: 35977662 DOI: 10.1016/j.clinre.2022.102009] [Reference Citation Analysis]
3 Yang F, Zhou L, Shen Y, Zhao S, Zheng Y, Men R, Fan X, Yang L. Metabolic heterogeneity caused by HLA-DRB1*04:05 and protective effect of inosine on autoimmune hepatitis. Front Immunol 2022;13:982186. [DOI: 10.3389/fimmu.2022.982186] [Reference Citation Analysis]
4 Bayhan I, Wahlin S, Efe C. Editorial: acute severe autoimmune hepatitis-a diagnostic and therapeutic dilemma. Aliment Pharmacol Ther 2022;56:170-1. [PMID: 35689316 DOI: 10.1111/apt.16981] [Reference Citation Analysis]
5 Zhang X, Jain D. The many faces and pathologic diagnostic challenges of autoimmune hepatitis. Hum Pathol 2022:S0046-8177(22)00164-2. [PMID: 35753409 DOI: 10.1016/j.humpath.2022.06.019] [Reference Citation Analysis]
6 Dalekos GN, Arvaniti P, Gatselis NK, Samakidou A, Gabeta S, Rigopoulou E, Koukoulis GK, Zachou K. First Results From a Propensity Matching Trial of Mycophenolate Mofetil vs. Azathioprine in Treatment-Naive AIH Patients. Front Immunol 2021;12:798602. [PMID: 35087524 DOI: 10.3389/fimmu.2021.798602] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Lin L, Lin B, Lan Q, Liu L, Lu J, Zhang X, Zheng S, Xue Y, Granito A. Presence of Serum Antinuclear Antibodies Does Not Impact Outcomes in HBV-Related Acute-on-Chronic Liver Failure. Canadian Journal of Gastroenterology and Hepatology 2022;2022:1-6. [DOI: 10.1155/2022/7981338] [Reference Citation Analysis]
8 Parveen S, Tiwari A, Ashraf A. Histology activity index: a benchmark for decision making. Hepatol Int. [DOI: 10.1007/s12072-021-10290-8] [Reference Citation Analysis]
9 Katsumi T, Ueno Y. Epidemiology and surveillance of autoimmune hepatitis in Asia. Liver Int 2022. [PMID: 34990076 DOI: 10.1111/liv.15155] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
10 Shorbagi AI. Is it time to get rid of the biopsy mandate in adults with suspected autoimmune hepatitis? Lessons from the COVID-19 pandemic. Liver Int 2021. [PMID: 34919326 DOI: 10.1111/liv.15137] [Reference Citation Analysis]
11 Efe C, Lammert C, Taşçılar K, Dhanasekaran R, Ebik B, Higuera-de la Tijera F, Calışkan AR, Peralta M, Gerussi A, Massoumi H, Catana AM, Purnak T, Rigamonti C, Aldana AJG, Khakoo N, Nazal L, Frager S, Demir N, Irak K, Melekoğlu-Ellik Z, Kacmaz H, Balaban Y, Atay K, Eren F, Alvares-da-Silva MR, Cristoferi L, Urzua Á, Eşkazan T, Magro B, Snijders R, Barutçu S, Lytvyak E, Zazueta GM, Demirezer-Bolat A, Aydın M, Heurgue-Berlot A, De Martin E, Ekin N, Yıldırım S, Yavuz A, Bıyık M, Narro GC, Kıyıcı M, Akyıldız M, Kahramanoğlu-Aksoy E, Vincent M, Carr RM, Günşar F, Reyes EC, Harputluoğlu M, Aloman C, Gatselis NK, Üstündağ Y, Brahm J, Vargas NCE, Güzelbulut F, Garcia SR, Aguirre J, Anders M, Ratusnu N, Hatemi I, Mendizabal M, Floreani A, Fagiuoli S, Silva M, Idilman R, Satapathy SK, Silveira M, Drenth JPH, Dalekos GN, N Assis D, Björnsson E, Boyer JL, Yoshida EM, Invernizzi P, Levy C, Montano-Loza AJ, Schiano TD, Ridruejo E, Wahlin S. Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis. Liver Int 2021. [PMID: 34846800 DOI: 10.1111/liv.15121] [Reference Citation Analysis]
12 Zachou K, Arvaniti P, Lyberopoulou A, Dalekos GN. Impact of genetic and environmental factors on autoimmune hepatitis. J Transl Autoimmun 2021;4:100125. [PMID: 34622188 DOI: 10.1016/j.jtauto.2021.100125] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]